Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder

Addiction. 2024 Jul;119(7):1313-1321. doi: 10.1111/add.16473. Epub 2024 Mar 22.

Abstract

Medications for opioid use disorder (MOUD) increase retention in care and decrease mortality during active treatment; however, information about the comparative effectiveness of different forms of MOUD is sparse. Observational comparative effectiveness studies are subject to many types of bias; a robust framework to minimize bias would improve the quality of comparative effectiveness evidence. This paper discusses the use of target trial emulation as a framework to conduct comparative effectiveness studies of MOUD with administrative data. Using examples from our planned research project comparing buprenorphine-naloxone and extended-release naltrexone with respect to the rates of MOUD discontinuation, we provide a primer on the challenges and approaches to employing target trial emulation in the study of MOUD.

Keywords: causal inference; emulated trial; observational research; opioids; substance use; target trial emulation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Buprenorphine / therapeutic use
  • Buprenorphine, Naloxone Drug Combination* / therapeutic use
  • Comparative Effectiveness Research*
  • Delayed-Action Preparations
  • Humans
  • Naloxone / therapeutic use
  • Naltrexone* / therapeutic use
  • Narcotic Antagonists* / therapeutic use
  • Observational Studies as Topic
  • Opiate Substitution Treatment* / methods
  • Opioid-Related Disorders* / drug therapy
  • Research Design

Substances

  • Narcotic Antagonists
  • Buprenorphine, Naloxone Drug Combination
  • Naltrexone
  • Buprenorphine
  • Delayed-Action Preparations
  • Naloxone